Course Summary
Contact Hour(s):
2.5 Contact Hours including 2.5 Advanced Pharmacology Hours
Author:
Dana Bartlett, RN, BSN, MA, CSPI
This peer-reviewed course is applicable for the following professions:
Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner
Accreditations:
The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)
CEUFast, Inc. is an AOTA Provider of professional development. PD activity approval ID# 10585. This distant learning-independent activity is offered at 0.25 CEUs Intermediate, Categories: Foundational Knowledge. The assignment of AOTA CEUs does not imply endorsement of specific course content, products, or clinical procedures.
State Approvals:
Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-767379; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy
Course Description:
This course discusses nutrition and heart health. It also discusses optimal blood lipid levels, such as triglycerides. The Dietary Approaches to Stop Hypertension (DASH) diet and Therapeutic Lifestyle Changes (TLC) are also reviewed.
Outcomes:
≥ 92% of participants will know how to care for a patient with hepatitis C.
Objectives:
After completing this course, the participant will be able to meet the following objectives:
- Summarize how hepatitis C is transmitted.
- Identify risk factors for hepatitis C transmission.
- Explain the two outcomes of acute exposure to hepatitis C.
- Determine the spontaneous clearance rate of acute hepatitis C exposure.
- Differentiate screening recommendations and tests used for diagnosing hepatitis C.
- Identify three extrahepatic complications of hepatitis C.
- Recommend drug therapy used to treat hepatitis C.
- Identify a United States (U.S.) Boxed Warning for direct-acting antiviral drugs used for hepatitis.
- Outline one lifestyle modification recommended for hepatitis C patients.
Disclosures:
CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.